4
Changes in Ownership
4D Molecular Therapeutics, Inc. Filed Acc 0000950170-24-034227
Chief Legal Officer sold 1,750 shares at $31.27 ($54,723)
- Chief Legal Officer acquired 1,750 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Bizily Scott Chief Legal Officer | 2024-03-18 | Option exercise 10b5-1 | +500 | $6.49 | $3,245 | 2,237 | D |
| Bizily Scott Chief Legal Officer | 2024-03-18 | Option exercise 10b5-1 | +1,250 | $8.04 | $10,050 | 3,487 | D |
| Bizily Scott Chief Legal Officer | 2024-03-18 | Sale 10b5-1 | −1,750 | $31.27 | $54,723 | 1,737 | D |
| Derivatives | |||||||
| Bizily Scott Chief Legal Officer | 2024-03-18 | Option exercise · Stock Option (Right To Buy) 10b5-1 | −500 | 16,043 | D | ||
| Bizily Scott Chief Legal Officer | 2024-03-18 | Option exercise · Stock Option (Right To Buy) 10b5-1 | −1,250 | 43,334 | D | ||
| Open-market sales · 1,750 sh · avg $31.27 · $54,723 | |||||||
Loading xslF345X05/ownership.xml…